13 min listen
NEJM Interview: Dr. Elliot Israel on the risks and benefits of long-acting beta agonists in the treatment of asthma and COPD.
FromNEJM Interviews
NEJM Interview: Dr. Elliot Israel on the risks and benefits of long-acting beta agonists in the treatment of asthma and COPD.
FromNEJM Interviews
ratings:
Length:
16 minutes
Released:
Dec 14, 2011
Format:
Podcast episode
Description
Dr. Elliot Israel is a Professor of Medicine at Harvard Medical School and the Director of Clinical Research in the Pulmonary and Critical Care Division at Brigham and Women's Hospital, both in Boston. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. Supplement to: Chowdhury B et al. The Risks and Benefits of Indracaterol - The FDA's Review. N Engl J Med 2011;365:2247-9.
Released:
Dec 14, 2011
Format:
Podcast episode
Titles in the series (100)
NEJM Interview: Dr. Robert Schwartz on the history of cancer research. by NEJM Interviews